Quantitative Imaging of Cerebral Thromboemboli In Vivo

Abstract

Thromboembolic burden and the efficacy of tPA therapy can be assessed serially, noninvasively, and quantitatively using high-resolution microcomputed tomography and a fibrin-binding nanoparticle imaging agent.